Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Radicle Crops specializes in the development of novel quinoa varieties using advanced genomic and phenotyping technologies. The company has commercialized high-yielding saponin-free quinoa lines optimized for mechanized cultivation. It recently acquired Wageningen University’s entire quinoa breeding program—including nine patented saponin-free varieties—and continues to innovate with F1 hybrid technology to accelerate global adoption of resilient crops like quinoa and white lupin. No clinical results as it is not a therapeutic developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Radicle Crops.